Development of 20(S)-Protopanaxadiol-Loaded SNEDDS Preconcentrate Using Comprehensive Phase Diagram for the Enhanced Dissolution and Oral Bioavailability.

Young Hoon Kim, Yu Chul Kim, Dong-Jin Jang, Kyoung Ah Min, Jenisha Karmacharya, Thi-Thao-Linh Nguyen, Han-Joo Maeng, Kwan Hyung Cho
Author Information
  1. Young Hoon Kim: College of Pharmacy and Inje Institute of Pharmaceutical Sciences and Research, Inje University, Gimhae 50834, Korea.
  2. Yu Chul Kim: Department of Pharmaceutical Engineering, Inje University, Gimhae 50834, Korea. ORCID
  3. Dong-Jin Jang: Department of Pharmaceutical Engineering, Inje University, Gimhae 50834, Korea.
  4. Kyoung Ah Min: College of Pharmacy and Inje Institute of Pharmaceutical Sciences and Research, Inje University, Gimhae 50834, Korea.
  5. Jenisha Karmacharya: College of Pharmacy, Gachon University, Incheon 21936, Korea.
  6. Thi-Thao-Linh Nguyen: College of Pharmacy, Gachon University, Incheon 21936, Korea. ORCID
  7. Han-Joo Maeng: College of Pharmacy, Gachon University, Incheon 21936, Korea.
  8. Kwan Hyung Cho: College of Pharmacy and Inje Institute of Pharmaceutical Sciences and Research, Inje University, Gimhae 50834, Korea.

Abstract

In this study, we aimed to develop a 20(S)-protopanaxadiol (PPD)-loaded self-nanoemulsifying drug delivery system (SNEDDS) preconcentrate (PSP) using comprehensive ternary phase diagrams for enhanced solubility, physical stability, dissolution, and bioavailability. Capmul MCM C8 and Capryol 90 were selected as the oil phase owing to the high solubility of PPD in these vehicles (>15%, w/w). Novel comprehensive ternary phase diagrams composed of selected oil, surfactant, and PPD were constructed, and the solubility of PPD and particle size of vehicle was indicated on them for the effective determination of PSP. PSPs were confirmed via particle size distribution, physical stability, and scanning electron microscope (SEM) with the dispersion of water. The optimized PSP (CAPRYOL90/Kolliphor EL/PPD = 54/36/10, weight%) obtained from the six possible comprehensive ternary phase diagrams showed a uniform nanoemulsion with the particle size of 125.07 ± 12.56 nm without any PPD precipitation. The PSP showed a dissolution rate of 94.69 ± 2.51% in 60 min at pH 1.2, whereas raw PPD showed negligible dissolution. In oral pharmacokinetic studies, the PSP group showed significantly higher C and AUC values (by 1.94- and 1.81-fold, respectively) than the raw PPD group ( < 0.05). In conclusion, the PSP formulation with outstanding solubilization, dissolution, and in-vivo oral bioavailability could be suggested using effective and comprehensive ternary phase diagrams.

Keywords

References

  1. Biomed Eng Online. 2013 Dec 31;12:134 [PMID: 24380420]
  2. J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Sep 15;1031:214-220 [PMID: 27507666]
  3. Carbohydr Polym. 2014 Nov 4;112:359-66 [PMID: 25129755]
  4. Int J Pharm. 2009 Aug 13;378(1-2):152-8 [PMID: 19463929]
  5. Mediators Inflamm. 2014;2014:748964 [PMID: 24833816]
  6. J Ginseng Res. 2018 Oct;42(4):512-523 [PMID: 30337812]
  7. AAPS PharmSciTech. 2008;9(2):628-34 [PMID: 18473177]
  8. AAPS PharmSciTech. 2019 Aug 6;20(7):275 [PMID: 31388863]
  9. Biol Pharm Bull. 2009 May;32(5):837-41 [PMID: 19420751]
  10. Pharmacology. 1991;42(4):223-9 [PMID: 1852782]
  11. Mol Med Rep. 2010 Sep-Oct;3(5):825-31 [PMID: 21472321]
  12. Int J Nanomedicine. 2018 Nov 05;13:7095-7106 [PMID: 30464461]
  13. Biol Pharm Bull. 2010;33(6):945-50 [PMID: 20522957]
  14. Basic Clin Pharmacol Toxicol. 2011 Oct;109(4):233-9 [PMID: 21443732]
  15. Pharmaceutics. 2018 Nov 28;10(4): [PMID: 30487449]
  16. Eur J Pharm Sci. 2015 Jul 10;74:1-10 [PMID: 25845633]
  17. Phytochemistry. 2014 Oct;106:7-24 [PMID: 25108743]
  18. Drug Dev Ind Pharm. 2015 Feb;41(2):224-31 [PMID: 24237326]
  19. Eur J Pharm Sci. 2006 Nov;29(3-4):278-87 [PMID: 16815001]
  20. Arch Toxicol. 2008 Feb;82(2):117-23 [PMID: 17598087]
  21. J Cell Biochem. 2017 Nov;118(11):3756-3764 [PMID: 28379603]
  22. Pharmacol Biochem Behav. 2003 Jun;75(3):687-700 [PMID: 12895687]
  23. Molecules. 2017 Feb 11;22(2): [PMID: 28208662]
  24. Drug Deliv. 2016 Sep;23(7):2410-2418 [PMID: 25564965]
  25. Pharmaceutics. 2019 Mar 06;11(3): [PMID: 30845766]

Grants

  1. NRF-2018R1A2B6002686; 2019R1F1A1058103/Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning
  2. Inje University 201902620001/Cosmonature Inc. (Yuseng-gu, Daejeon, Republic of Korea)

Word Cloud

Created with Highcharts 10.0.0PPDPSPphasecomprehensiveternarydiagramsdissolutionshowed20Ssolubilitybioavailabilityparticlesize1oral-protopanaxadiolself-nanoemulsifyingdrugdeliverysystemSNEDDSusingphysicalstabilityselectedoileffective±2rawgroupstudyaimeddevelop-loadedpreconcentrateenhancedCapmulMCMC8Capryol90owinghighvehicles>15%w/wNovelcomposedsurfactantconstructedvehicleindicateddeterminationPSPsconfirmedviadistributionscanningelectronmicroscopeSEMdispersionwateroptimizedCAPRYOL90/KolliphorEL/PPD=54/36/10weight%obtainedsixpossibleuniformnanoemulsion125071256nmwithoutprecipitationrate946951%60minpHwhereasnegligiblepharmacokineticstudiessignificantlyhigherCAUCvalues94-81-foldrespectively<005conclusionformulationoutstandingsolubilizationin-vivosuggestedDevelopment-Protopanaxadiol-LoadedPreconcentrateUsingComprehensivePhaseDiagramEnhancedDissolutionOralBioavailabilitydiagram

Similar Articles

Cited By (2)